Linked Life Data

20624171

Source:http://linkedlifedata.com/resource/pubmed/id/20624171

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2010-9-21
pubmed:abstractText
The fibroblast growth factor 21 (FGF21) hormonal pathway is a metabolic signalling cascade and has been recently identified as the master hormonal regulator of glucose, lipids and overall energy balance. In this observational, case-control study, we assayed serum levels of FGF21 in patients with nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of the metabolic syndrome, and examined their association with clinical, biochemical and histological phenotypes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1365-2362
pubmed:author
pubmed:copyrightInfo
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
887-92
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.
pubmed:affiliation
Department of Gastroenterology, Marmara University School of Medicine, Altunizade, Istanbul, Turkey. yusufyilmaz@uludag.edu.tr
pubmed:publicationType
Journal Article